nodes	percent_of_prediction	percent_of_DWPC	metapath
Alosetron—CYP1A2—Riluzole—amyotrophic lateral sclerosis	0.666	1	CbGbCtD
Alosetron—Blood bilirubin abnormal—Riluzole—amyotrophic lateral sclerosis	0.112	0.34	CcSEcCtD
Alosetron—Proctitis—Riluzole—amyotrophic lateral sclerosis	0.0276	0.084	CcSEcCtD
Alosetron—Cholecystitis—Riluzole—amyotrophic lateral sclerosis	0.0117	0.0357	CcSEcCtD
Alosetron—Ileus—Riluzole—amyotrophic lateral sclerosis	0.00953	0.029	CcSEcCtD
Alosetron—Laryngitis—Riluzole—amyotrophic lateral sclerosis	0.00935	0.0284	CcSEcCtD
Alosetron—Musculoskeletal stiffness—Riluzole—amyotrophic lateral sclerosis	0.00752	0.0229	CcSEcCtD
Alosetron—Ulcer—Riluzole—amyotrophic lateral sclerosis	0.00713	0.0217	CcSEcCtD
Alosetron—Abnormal dreams—Riluzole—amyotrophic lateral sclerosis	0.00666	0.0203	CcSEcCtD
Alosetron—Photophobia—Riluzole—amyotrophic lateral sclerosis	0.00633	0.0193	CcSEcCtD
Alosetron—Eczema—Riluzole—amyotrophic lateral sclerosis	0.00545	0.0166	CcSEcCtD
Alosetron—Injury—Riluzole—amyotrophic lateral sclerosis	0.00532	0.0162	CcSEcCtD
Alosetron—Gastritis—Riluzole—amyotrophic lateral sclerosis	0.00433	0.0132	CcSEcCtD
Alosetron—Alanine aminotransferase increased—Riluzole—amyotrophic lateral sclerosis	0.00432	0.0131	CcSEcCtD
Alosetron—Abdominal distension—Riluzole—amyotrophic lateral sclerosis	0.00426	0.013	CcSEcCtD
Alosetron—Abdominal discomfort—Riluzole—amyotrophic lateral sclerosis	0.00406	0.0123	CcSEcCtD
Alosetron—Pollakiuria—Riluzole—amyotrophic lateral sclerosis	0.00391	0.0119	CcSEcCtD
Alosetron—Depression—Riluzole—amyotrophic lateral sclerosis	0.00376	0.0114	CcSEcCtD
Alosetron—Jaundice—Riluzole—amyotrophic lateral sclerosis	0.00368	0.0112	CcSEcCtD
Alosetron—Urinary tract infection—Riluzole—amyotrophic lateral sclerosis	0.00367	0.0111	CcSEcCtD
Alosetron—Sweating—Riluzole—amyotrophic lateral sclerosis	0.00362	0.011	CcSEcCtD
Alosetron—Sinusitis—Riluzole—amyotrophic lateral sclerosis	0.00354	0.0108	CcSEcCtD
Alosetron—Haemoglobin—Riluzole—amyotrophic lateral sclerosis	0.0034	0.0103	CcSEcCtD
Alosetron—Hepatitis—Riluzole—amyotrophic lateral sclerosis	0.00339	0.0103	CcSEcCtD
Alosetron—Haemorrhage—Riluzole—amyotrophic lateral sclerosis	0.00339	0.0103	CcSEcCtD
Alosetron—Hypoaesthesia—Riluzole—amyotrophic lateral sclerosis	0.00337	0.0102	CcSEcCtD
Alosetron—Arrhythmia—Riluzole—amyotrophic lateral sclerosis	0.00302	0.0092	CcSEcCtD
Alosetron—Alopecia—Riluzole—amyotrophic lateral sclerosis	0.00299	0.0091	CcSEcCtD
Alosetron—Flatulence—Riluzole—amyotrophic lateral sclerosis	0.0029	0.00883	CcSEcCtD
Alosetron—Muscle spasms—Riluzole—amyotrophic lateral sclerosis	0.00283	0.00862	CcSEcCtD
Alosetron—Tremor—Riluzole—amyotrophic lateral sclerosis	0.00276	0.0084	CcSEcCtD
Alosetron—Ill-defined disorder—Riluzole—amyotrophic lateral sclerosis	0.00273	0.00832	CcSEcCtD
Alosetron—Malaise—Riluzole—amyotrophic lateral sclerosis	0.00266	0.00808	CcSEcCtD
Alosetron—Cough—Riluzole—amyotrophic lateral sclerosis	0.00257	0.00782	CcSEcCtD
Alosetron—Hypertension—Riluzole—amyotrophic lateral sclerosis	0.00254	0.00774	CcSEcCtD
Alosetron—Myalgia—Riluzole—amyotrophic lateral sclerosis	0.00251	0.00763	CcSEcCtD
Alosetron—Anxiety—Riluzole—amyotrophic lateral sclerosis	0.0025	0.0076	CcSEcCtD
Alosetron—Discomfort—Riluzole—amyotrophic lateral sclerosis	0.00248	0.00754	CcSEcCtD
Alosetron—Dry mouth—Riluzole—amyotrophic lateral sclerosis	0.00245	0.00746	CcSEcCtD
Alosetron—Confusional state—Riluzole—amyotrophic lateral sclerosis	0.00243	0.00738	CcSEcCtD
Alosetron—Infection—Riluzole—amyotrophic lateral sclerosis	0.00239	0.00727	CcSEcCtD
Alosetron—Skin disorder—Riluzole—amyotrophic lateral sclerosis	0.00234	0.00711	CcSEcCtD
Alosetron—Hyperhidrosis—Riluzole—amyotrophic lateral sclerosis	0.00233	0.00707	CcSEcCtD
Alosetron—Musculoskeletal discomfort—Riluzole—amyotrophic lateral sclerosis	0.00219	0.00666	CcSEcCtD
Alosetron—Fatigue—Riluzole—amyotrophic lateral sclerosis	0.00207	0.00631	CcSEcCtD
Alosetron—Constipation—Riluzole—amyotrophic lateral sclerosis	0.00206	0.00626	CcSEcCtD
Alosetron—Pain—Riluzole—amyotrophic lateral sclerosis	0.00206	0.00626	CcSEcCtD
Alosetron—Feeling abnormal—Riluzole—amyotrophic lateral sclerosis	0.00198	0.00603	CcSEcCtD
Alosetron—HTR3A—cranial nerve—amyotrophic lateral sclerosis	0.00193	0.406	CbGeAlD
Alosetron—Urticaria—Riluzole—amyotrophic lateral sclerosis	0.00191	0.00581	CcSEcCtD
Alosetron—Hypersensitivity—Riluzole—amyotrophic lateral sclerosis	0.00177	0.00539	CcSEcCtD
Alosetron—Asthenia—Riluzole—amyotrophic lateral sclerosis	0.00173	0.00525	CcSEcCtD
Alosetron—Vomiting—Riluzole—amyotrophic lateral sclerosis	0.00153	0.00465	CcSEcCtD
Alosetron—Rash—Riluzole—amyotrophic lateral sclerosis	0.00152	0.00461	CcSEcCtD
Alosetron—Dermatitis—Riluzole—amyotrophic lateral sclerosis	0.00152	0.00461	CcSEcCtD
Alosetron—Headache—Riluzole—amyotrophic lateral sclerosis	0.00151	0.00458	CcSEcCtD
Alosetron—Nausea—Riluzole—amyotrophic lateral sclerosis	0.00143	0.00435	CcSEcCtD
Alosetron—HTR3A—nerve—amyotrophic lateral sclerosis	0.000989	0.208	CbGeAlD
Alosetron—HTR3A—brainstem—amyotrophic lateral sclerosis	0.000425	0.0893	CbGeAlD
Alosetron—HTR3A—nervous system—amyotrophic lateral sclerosis	0.000222	0.0468	CbGeAlD
Alosetron—HTR3A—central nervous system—amyotrophic lateral sclerosis	0.000214	0.0451	CbGeAlD
Alosetron—HTR3A—brain—amyotrophic lateral sclerosis	0.00017	0.0358	CbGeAlD
Alosetron—CYP2E1—medulla oblongata—amyotrophic lateral sclerosis	0.000137	0.0289	CbGeAlD
Alosetron—CYP2E1—spinal cord—amyotrophic lateral sclerosis	0.000123	0.0258	CbGeAlD
Alosetron—CYP2E1—nervous system—amyotrophic lateral sclerosis	0.000103	0.0217	CbGeAlD
Alosetron—CYP2E1—central nervous system—amyotrophic lateral sclerosis	9.94e-05	0.0209	CbGeAlD
Alosetron—CYP2E1—cerebellum—amyotrophic lateral sclerosis	9.72e-05	0.0204	CbGeAlD
Alosetron—CYP3A4—nervous system—amyotrophic lateral sclerosis	8.31e-05	0.0175	CbGeAlD
Alosetron—CYP3A4—central nervous system—amyotrophic lateral sclerosis	8e-05	0.0168	CbGeAlD
Alosetron—CYP2E1—brain—amyotrophic lateral sclerosis	7.89e-05	0.0166	CbGeAlD
